Back to RPRX
KBC Group NV RPRX Position History
Royalty Pharma plc
Quarters held
15
Latest value
$60K
Q3 2026
Peak value
$23.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.8M |
| Q3 2025 | $6.6M |
| Q3 2025 | $51K |
| Q4 2025 | $5M |
| Q4 2025 | $6.3M |
| Q4 2025 | $19K |
| Q1 2026 | $19.7M |
| Q1 2026 | $3M |
| Q1 2026 | $24K |
| Q2 2026 | $23.4M |
| Q2 2026 | $3.9M |
| Q2 2026 | $58K |
| Q3 2026 | $23.5M |
| Q3 2026 | $5.1M |
| Q3 2026 | $60K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $60K | 1.0K | — | — |
| Q3 2026 | $5.1M | 86.6K | — | — |
| Q3 2026 | $23.5M | 481.5K | — | — |
| Q2 2026 | $58K | 1.0K | — | — |
| Q2 2026 | $3.9M | 69.6K | — | — |
| Q2 2026 | $23.4M | 503.3K | — | — |
| Q1 2026 | $24K | 500 | — | — |
| Q1 2026 | $3M | 62.7K | — | — |
| Q1 2026 | $19.7M | 383.3K | — | — |
| Q4 2025 | $19K | 500 | — | — |
| Q4 2025 | $6.3M | 163.1K | — | — |
| Q4 2025 | $5M | 130.2K | — | — |
| Q3 2025 | $51K | 1.4K | — | — |
| Q3 2025 | $6.6M | 186.5K | — | — |
| Q3 2025 | $3.8M | 110.5K | — | — |